Page last updated: 2024-11-05

tosufloxacin and Carcinoma, Squamous Cell

tosufloxacin has been researched along with Carcinoma, Squamous Cell in 1 studies

tosufloxacin: quinolone anti-infective agent; structure given in first source
tosufloxacin : A racemate comprising equimolar amounts of (R)- and (S)-tosufloxacin.
7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid : A 1,8-naphthyridine derivative that is 4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid bearing additional 2,4-difluorophenyl, fluoro and 3-aminopyrrolidin-1-yl substituents at positions 1, 6 and 7 respectively.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, T1
Tanida, T1
Ueta, E1
Kimura, T1
Doi, S1
Osaki, T1

Other Studies

1 other study available for tosufloxacin and Carcinoma, Squamous Cell

ArticleYear
Pulmonary infiltration with eosinophilia (PIE) syndrome induced by antibiotics, PIPC and TFLX during cancer treatment.
    Oral oncology, 2001, Volume: 37, Issue:5

    Topics: 4-Quinolones; Aged; Aged, 80 and over; Anti-Infective Agents; Carcinoma, Squamous Cell; Fatal Outcom

2001